Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Parharn
    Member
    • Jul 2013
    • 84

    #1

    Zero output for sel.rn=rowSums(cnts) != 0

    I get a problem when I want to try step 2 from "RNA-seq data pathway and gene-set analysis workflow" by Weijun Luo. I get zero rows with value !=0.

    Code:
    > p.cnts=assay(gnCnt)
    > cnts=p.cnts
    > dim(cnts)
    [1] 7017    2
    > sel.rn=rowSums(cnts) !=0
    > cnts=cnts[sel.rn,]
    > dim(cnts)
    [1] 0 2
    When I check my BAM files with IGV it looks that I have mapped reads all over the genome.
    Any advise?
  • bigmw
    Senior Member
    • Aug 2013
    • 124

    #2
    I haven’t seen your data and exactly how you did your reads mapping and counting. But please make sure on two things:
    First, you use the same version of reference genome at the TopHat step and in your TranscriptDb object.
    Second, you specify the right parameters in the reads counting step. They are different for single- vs paired-end data. The workflow example is for paired-end data. Single end data are treated differently:
    …
    flag <- scanBamFlag(isNotPrimaryRead=FALSE, isProperPair=NA)
    param <- ScanBamParam(flag=flag)
    gnCnt <- summarizeOverlaps(exByGn, bamfls, mode="Union", ignore.strand=TRUE, single.end=TRUE, param=param)
    …

    Please check help info for details:
    ?scanBamFlag
    ?summarizeOverlaps

    Comment

    • Parharn
      Member
      • Jul 2013
      • 84

      #3
      Yes I got help in another thread, you are right. Thanks a lot though.
      Here is the other thread just if any one wanted to know more.
      https://www.biostars.org/p/103482/#103584

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...